AIMS: Whereas cortical EEG effects of benzodiazepines are well characterized, information about benzodiazepine effects in other areas of the central nervous system is sparse. This study investigated the action of midazolam and its active metabolite alpha-hydroxy-midazolam on different parts of the auditory pathway in six healthy volunteers in a randomized, double-blind, three-way cross-over study. METHODS:Acoustically evoked short (SLP) and middle (MLP) latency potentials, transitory evoked otoacoustic emissions (TEOAE), and EEG power spectra were analysed after short i. v. injections of placebo, or 0.15 mg kg-1 midazolam, or alpha-hydroxy-midazolam, respectively. RESULTS: All subjects fell asleep during the 4 min infusion of active drug. SLP showed a significant transient increase of Jewett wave V 10 min after injection for midazolam and alpha-hydroxy-midazolam while the latency of wave I was unchanged. Both benzodiazepines induced a marked and long-lasting MLP amplitude decrease for 240 min with slow recovery over the following 360 min. No changes of TEOAE were observed. In agreement with earlier reports, increases in EEG beta activity and decreases in alpha activity were observed after administration of either drug. CONCLUSIONS: Systemically administered benzodiazepines modulate the auditory pathway above the level of the cochlea. While SLP changes were closely associated with sedation and high plasma benzodiazepine concentrations, MLP effects persisted for hours after sedation even at low benzodiazepine plasma levels. Evoked potentials may therefore be more sensitive than EEG as a tool to monitor benzodiazepine effects.
RCT Entities:
AIMS: Whereas cortical EEG effects of benzodiazepines are well characterized, information about benzodiazepine effects in other areas of the central nervous system is sparse. This study investigated the action of midazolam and its active metabolite alpha-hydroxy-midazolam on different parts of the auditory pathway in six healthy volunteers in a randomized, double-blind, three-way cross-over study. METHODS: Acoustically evoked short (SLP) and middle (MLP) latency potentials, transitory evoked otoacoustic emissions (TEOAE), and EEG power spectra were analysed after short i. v. injections of placebo, or 0.15 mg kg-1 midazolam, or alpha-hydroxy-midazolam, respectively. RESULTS: All subjects fell asleep during the 4 min infusion of active drug. SLP showed a significant transient increase of Jewett wave V 10 min after injection for midazolam and alpha-hydroxy-midazolam while the latency of wave I was unchanged. Both benzodiazepines induced a marked and long-lasting MLP amplitude decrease for 240 min with slow recovery over the following 360 min. No changes of TEOAE were observed. In agreement with earlier reports, increases in EEG beta activity and decreases in alpha activity were observed after administration of either drug. CONCLUSIONS: Systemically administered benzodiazepines modulate the auditory pathway above the level of the cochlea. While SLP changes were closely associated with sedation and high plasma benzodiazepine concentrations, MLP effects persisted for hours after sedation even at low benzodiazepine plasma levels. Evoked potentials may therefore be more sensitive than EEG as a tool to monitor benzodiazepine effects.
Authors: L D Bornemann; B H Min; T Crews; M M Rees; H P Blumenthal; W A Colburn; I H Patel Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953
Authors: Joseph D Ma; Anne N Nafziger; William Mylott; David B Haughey; Mario L Rocci; Joseph S Bertino Journal: Br J Clin Pharmacol Date: 2008-12-12 Impact factor: 4.335
Authors: Yomna M Nassar; Nicolas Hohmann; Gerd Mikus; Charlotte Kloft; Robin Michelet; Katharina Gottwalt; Andreas D Meid; Jürgen Burhenne; Wilhelm Huisinga; Walter E Haefeli Journal: Clin Pharmacokinet Date: 2022-10-04 Impact factor: 5.577
Authors: How Sung Lee; Boon Cher Goh; Lu Fan; Yok Moi Khoo; Lingzhi Wang; Robert Lim; Ai Bee Ong; Charlotte Chua Journal: Br J Clin Pharmacol Date: 2003-03 Impact factor: 4.335
Authors: Tianne Numan; Edwin van Dellen; Frank P Vleggaar; Paul van Vlieberghe; Cornelis J Stam; Arjen J C Slooter Journal: Clin EEG Neurosci Date: 2019-05-20 Impact factor: 1.843
Authors: Willem J M I Verbeke; Rumen Pozharliev; Jan W Van Strien; Frank Belschak; Richard P Bagozzi Journal: Front Hum Neurosci Date: 2014-07-11 Impact factor: 3.169